Cite

HARVARD Citation

    Brock, P. et al. (n.d.). 542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19. Open forum infectious diseases. pp. S372-S373. [Online]. 
  
Back to record